Press Releases
Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing
Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series
Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19
Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights
Ceapro Inc. to Present at the April 2020 Virtual Investor Summit
Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch
Ceapro Inc. to Present at Noble Capital Markets’ 16th Annual Investor Conference
Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
